Gut Bacterial Community Determines the Therapeutic Effect of Ginsenoside on Canine Inflammatory Bowel Disease by Modulating the Colonic Mucosal Barrier

Inflammatory bowel disease (IBD) comprises systemic inflammatory conditions primarily affecting the gastrointestinal tract, including Crohn’s disease and ulcerative colitis. This research aims to analyze the clinical symptoms and pathogenesis of a Dextran sodium sulfate (DSS)-induced canine IBD mode...

Full description

Bibliographic Details
Main Authors: Aipeng Mao, Weigang Zhao, Yuhang Zhu, Fantao Kong, Danyang Chen, Huazhe Si, Chao Xu
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Microorganisms
Subjects:
Online Access:https://www.mdpi.com/2076-2607/11/11/2616
_version_ 1797458318208270336
author Aipeng Mao
Weigang Zhao
Yuhang Zhu
Fantao Kong
Danyang Chen
Huazhe Si
Chao Xu
author_facet Aipeng Mao
Weigang Zhao
Yuhang Zhu
Fantao Kong
Danyang Chen
Huazhe Si
Chao Xu
author_sort Aipeng Mao
collection DOAJ
description Inflammatory bowel disease (IBD) comprises systemic inflammatory conditions primarily affecting the gastrointestinal tract, including Crohn’s disease and ulcerative colitis. This research aims to analyze the clinical symptoms and pathogenesis of a Dextran sodium sulfate (DSS)-induced canine IBD model and evaluate the restorative effect of ginsenoside from a pathogenesis perspective. We established the DSS-induced canine IBD model and studied the pathological mechanisms. Additionally, we examined the therapeutic effect of ginsenosides by assessing the Canine Inflammatory Bowel Disease Activity Index (CIBDAI), C-reactive protein (CRP) levels, colonic tissue morphology, protein expression, and mucosal bacterial community analysis. Our findings revealed a total ginsenoside content of 22.7% in the ginsenoside extract. Animal experiments demonstrated that dogs with IBD exhibited decreased mental state, significantly increased CIBDAI and CRP levels, disrupted colonic epithelial tissue structure, decreased expression of mucin, tight junctions, and adherens junctions, as well as reduced diversity of the colonic mucosal bacterial community. Furthermore, correlation analysis highlighted a total of 38 bacterial strains correlated with physiological indices. Significantly, ginsenoside treatment could improve these symptoms and reverse the relative abundance of some bacterial communities. In conclusion, alterations in the properties of the colonic mucus layer or the reduction in MUC2, its core component, in dogs with IBD can lead to bacterial penetration of the mucus layer and subsequent contact with intestinal epithelial cells, resulting in inflammation. Remarkably, ginsenoside intervention showcased the capacity to positively influence the relative abundance of bacteria and impact the colonic mucus layer properties, thereby offering promising prospects for IBD management and recovery.
first_indexed 2024-03-09T16:36:21Z
format Article
id doaj.art-87862fd5d44040dab5aa11b928174cb9
institution Directory Open Access Journal
issn 2076-2607
language English
last_indexed 2024-03-09T16:36:21Z
publishDate 2023-10-01
publisher MDPI AG
record_format Article
series Microorganisms
spelling doaj.art-87862fd5d44040dab5aa11b928174cb92023-11-24T14:56:40ZengMDPI AGMicroorganisms2076-26072023-10-011111261610.3390/microorganisms11112616Gut Bacterial Community Determines the Therapeutic Effect of Ginsenoside on Canine Inflammatory Bowel Disease by Modulating the Colonic Mucosal BarrierAipeng Mao0Weigang Zhao1Yuhang Zhu2Fantao Kong3Danyang Chen4Huazhe Si5Chao Xu6Institute of Special Animal and Plant Sciences, Chinese Academy of Agricultural Sciences, Research Center for Microbial Feed Engineering of Special Animals in Jilin Province, Innovation Center for Feeding and Utilization of Special Animals in Jilin Province, Changchun 130112, ChinaInstitute of Special Animal and Plant Sciences, Chinese Academy of Agricultural Sciences, Research Center for Microbial Feed Engineering of Special Animals in Jilin Province, Innovation Center for Feeding and Utilization of Special Animals in Jilin Province, Changchun 130112, ChinaCollege of Animal Science and Technology, Jilin Agricultural University, Changchun 130118, ChinaInstitute of Special Animal and Plant Sciences, Chinese Academy of Agricultural Sciences, Research Center for Microbial Feed Engineering of Special Animals in Jilin Province, Innovation Center for Feeding and Utilization of Special Animals in Jilin Province, Changchun 130112, ChinaInstitute of Special Animal and Plant Sciences, Chinese Academy of Agricultural Sciences, Research Center for Microbial Feed Engineering of Special Animals in Jilin Province, Innovation Center for Feeding and Utilization of Special Animals in Jilin Province, Changchun 130112, ChinaCollege of Animal Science and Technology, Jilin Agricultural University, Changchun 130118, ChinaInstitute of Special Animal and Plant Sciences, Chinese Academy of Agricultural Sciences, Research Center for Microbial Feed Engineering of Special Animals in Jilin Province, Innovation Center for Feeding and Utilization of Special Animals in Jilin Province, Changchun 130112, ChinaInflammatory bowel disease (IBD) comprises systemic inflammatory conditions primarily affecting the gastrointestinal tract, including Crohn’s disease and ulcerative colitis. This research aims to analyze the clinical symptoms and pathogenesis of a Dextran sodium sulfate (DSS)-induced canine IBD model and evaluate the restorative effect of ginsenoside from a pathogenesis perspective. We established the DSS-induced canine IBD model and studied the pathological mechanisms. Additionally, we examined the therapeutic effect of ginsenosides by assessing the Canine Inflammatory Bowel Disease Activity Index (CIBDAI), C-reactive protein (CRP) levels, colonic tissue morphology, protein expression, and mucosal bacterial community analysis. Our findings revealed a total ginsenoside content of 22.7% in the ginsenoside extract. Animal experiments demonstrated that dogs with IBD exhibited decreased mental state, significantly increased CIBDAI and CRP levels, disrupted colonic epithelial tissue structure, decreased expression of mucin, tight junctions, and adherens junctions, as well as reduced diversity of the colonic mucosal bacterial community. Furthermore, correlation analysis highlighted a total of 38 bacterial strains correlated with physiological indices. Significantly, ginsenoside treatment could improve these symptoms and reverse the relative abundance of some bacterial communities. In conclusion, alterations in the properties of the colonic mucus layer or the reduction in MUC2, its core component, in dogs with IBD can lead to bacterial penetration of the mucus layer and subsequent contact with intestinal epithelial cells, resulting in inflammation. Remarkably, ginsenoside intervention showcased the capacity to positively influence the relative abundance of bacteria and impact the colonic mucus layer properties, thereby offering promising prospects for IBD management and recovery.https://www.mdpi.com/2076-2607/11/11/2616ginsenosideinflammatory bowel diseasetight junction proteinadherens junction proteinmucosal bacterial community
spellingShingle Aipeng Mao
Weigang Zhao
Yuhang Zhu
Fantao Kong
Danyang Chen
Huazhe Si
Chao Xu
Gut Bacterial Community Determines the Therapeutic Effect of Ginsenoside on Canine Inflammatory Bowel Disease by Modulating the Colonic Mucosal Barrier
Microorganisms
ginsenoside
inflammatory bowel disease
tight junction protein
adherens junction protein
mucosal bacterial community
title Gut Bacterial Community Determines the Therapeutic Effect of Ginsenoside on Canine Inflammatory Bowel Disease by Modulating the Colonic Mucosal Barrier
title_full Gut Bacterial Community Determines the Therapeutic Effect of Ginsenoside on Canine Inflammatory Bowel Disease by Modulating the Colonic Mucosal Barrier
title_fullStr Gut Bacterial Community Determines the Therapeutic Effect of Ginsenoside on Canine Inflammatory Bowel Disease by Modulating the Colonic Mucosal Barrier
title_full_unstemmed Gut Bacterial Community Determines the Therapeutic Effect of Ginsenoside on Canine Inflammatory Bowel Disease by Modulating the Colonic Mucosal Barrier
title_short Gut Bacterial Community Determines the Therapeutic Effect of Ginsenoside on Canine Inflammatory Bowel Disease by Modulating the Colonic Mucosal Barrier
title_sort gut bacterial community determines the therapeutic effect of ginsenoside on canine inflammatory bowel disease by modulating the colonic mucosal barrier
topic ginsenoside
inflammatory bowel disease
tight junction protein
adherens junction protein
mucosal bacterial community
url https://www.mdpi.com/2076-2607/11/11/2616
work_keys_str_mv AT aipengmao gutbacterialcommunitydeterminesthetherapeuticeffectofginsenosideoncanineinflammatoryboweldiseasebymodulatingthecolonicmucosalbarrier
AT weigangzhao gutbacterialcommunitydeterminesthetherapeuticeffectofginsenosideoncanineinflammatoryboweldiseasebymodulatingthecolonicmucosalbarrier
AT yuhangzhu gutbacterialcommunitydeterminesthetherapeuticeffectofginsenosideoncanineinflammatoryboweldiseasebymodulatingthecolonicmucosalbarrier
AT fantaokong gutbacterialcommunitydeterminesthetherapeuticeffectofginsenosideoncanineinflammatoryboweldiseasebymodulatingthecolonicmucosalbarrier
AT danyangchen gutbacterialcommunitydeterminesthetherapeuticeffectofginsenosideoncanineinflammatoryboweldiseasebymodulatingthecolonicmucosalbarrier
AT huazhesi gutbacterialcommunitydeterminesthetherapeuticeffectofginsenosideoncanineinflammatoryboweldiseasebymodulatingthecolonicmucosalbarrier
AT chaoxu gutbacterialcommunitydeterminesthetherapeuticeffectofginsenosideoncanineinflammatoryboweldiseasebymodulatingthecolonicmucosalbarrier